A new scientific review concludes that marijuana’s restrictive federal classification as a Schedule I drug — implying high danger and no accepted medical use — isn’t supported by current science. Researchers argue that marijuana and some other substances are less harmful than laws written nearly 50 years ago suggest, highlighting a mismatch between federal drug policy and evidence on risk and medical potential. The findings add pressure to rescheduling and updated regulations.
